JP2013510817A - 膠芽腫治療用生体適合性磁性ナノ粒子 - Google Patents
膠芽腫治療用生体適合性磁性ナノ粒子 Download PDFInfo
- Publication number
- JP2013510817A JP2013510817A JP2012538311A JP2012538311A JP2013510817A JP 2013510817 A JP2013510817 A JP 2013510817A JP 2012538311 A JP2012538311 A JP 2012538311A JP 2012538311 A JP2012538311 A JP 2012538311A JP 2013510817 A JP2013510817 A JP 2013510817A
- Authority
- JP
- Japan
- Prior art keywords
- nanoparticle
- nanoparticle according
- glioblastoma
- nanoparticles
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Magnetic Treatment Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Hard Magnetic Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
【選択図】なし
Description
Claims (11)
- 静磁場で膠芽腫治療に使用される生体適合性磁性ナノ粒子であって、
前記生体適合性磁性ナノ粒子が、転移性癌細胞を集合体として外科的処置又は温熱療法で取り扱えるようにするために、外部磁場下(走磁性)における前記癌細胞の目的とされた移動のために使用される、
ナノ粒子。 - 流体力学的大きさが、1μm未満、好ましくは5nm〜300nmの範囲、特に好ましくは50nm〜200nmの範囲にある
ことを特徴とする請求項1に記載のナノ粒子。 - 核の直径が、1nm〜300nm、好ましくは3nm〜50nmである
ことを特徴とする請求項1又は請求項2に記載のナノ粒子。 - 鉄(Fe)、ガドリニウム(Gd)又はこれらの酸化物から選択される
ことを特徴とする請求項1から請求項3のいずれか一項に記載のナノ粒子。 - マグネタイト又はマグヘマイトから選択される
ことを特徴とする請求項4に記載のナノ粒子。 - 外殻物質を有する
ことを特徴とする請求項1から請求項5のいずれか一項に記載のナノ粒子。 - 前記外殻物質が、デキストラン、カルボキシデキストラン、ポリエチレングリコール、澱粉、アルブミン等の重合体、あるいは、脂質、ミリスチン酸若しくはラウリン酸のような脂肪酸、又はシトレート等のバイオメティック物質から選択される
ことを特徴とする請求項6に記載のナノ粒子。 - 前記外殻物質が更に抗体を含む
ことを特徴とする請求項6又は請求項7に記載のナノ粒子。 - 一つ以上の前記抗体が、膠芽腫細胞の表面抗原に特異的に結合する
ことを特徴とする請求項8に記載のナノ粒子。 - 前記ナノ粒子が、静磁性細菌由来のマグネトソームである
ことを特徴とする請求項1から請求項9のいずれか一項に記載のナノ粒子。 - 前記マグネトソームが、Magnetospirillum gryphiswaldense MSR-1,Magnetospirillium magnetotacticum,Magnetospirillium種AMB-1,磁性球菌MC-1又は磁性Vibrio MC-1から得られる
ことを特徴とする請求項6に記載のナノ粒子。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09175794.8A EP2322142B1 (de) | 2009-11-12 | 2009-11-12 | Biokompatible, magnetische Nanopartikel zur Behandlung von Glioblastomen |
EP09175794.8 | 2009-11-12 | ||
PCT/EP2010/067139 WO2011058018A2 (de) | 2009-11-12 | 2010-11-09 | Biokompatible, magnetische nanopartikel zur behandlung von glioblastomen |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2013510817A true JP2013510817A (ja) | 2013-03-28 |
Family
ID=42041720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012538311A Pending JP2013510817A (ja) | 2009-11-12 | 2010-11-09 | 膠芽腫治療用生体適合性磁性ナノ粒子 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20120283504A1 (ja) |
EP (1) | EP2322142B1 (ja) |
JP (1) | JP2013510817A (ja) |
ES (1) | ES2600229T3 (ja) |
WO (1) | WO2011058018A2 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9005151B2 (en) | 2011-09-07 | 2015-04-14 | Choon Kee Lee | Thermal apparatus |
DE102013108453A1 (de) * | 2013-08-06 | 2015-02-12 | Yerzhan Ussembayev | Nanocomposites zur Einkapselung von Zellen und Verfahren zur Behandlung von Krankheiten |
CN109283326A (zh) * | 2018-12-21 | 2019-01-29 | 湖南华腾制药有限公司 | 偶联有链霉亲和素的磁小体及生物分离、免疫检测方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008536837A (ja) * | 2005-04-12 | 2008-09-11 | マグフォース ナノテクノロジーズ アーゲー | ナノ粒子/活性成分結合体 |
WO2009070282A1 (en) * | 2007-11-26 | 2009-06-04 | Stc.Unm | Active nanoparticles and method of using |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4428851C2 (de) * | 1994-08-04 | 2000-05-04 | Diagnostikforschung Inst | Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie |
US20050090732A1 (en) * | 2003-10-28 | 2005-04-28 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles |
WO2005065282A2 (en) * | 2003-12-31 | 2005-07-21 | The Regents Of The University Of California | Remote magnetically induced treatment of cancer |
KR100821192B1 (ko) * | 2005-09-08 | 2008-04-11 | 주식회사바이테리얼즈 | 형광성을 가지는 자성 나노 입자 및 그 제조방법 |
US8647604B2 (en) * | 2006-01-25 | 2014-02-11 | Uvic Industry Partnerships Inc. | Lanthanide rich nanoparticles, and their investigative uses in MRI and related technologies |
US8323694B2 (en) * | 2007-05-09 | 2012-12-04 | Nanoprobes, Inc. | Gold nanoparticles for selective IR heating |
DE102008008522A1 (de) * | 2008-02-11 | 2009-08-13 | Magforce Nanotechnologies Ag | Implantierbare Nanopartikel-enthaltende Produkte |
GB0811856D0 (en) * | 2008-06-27 | 2008-07-30 | Ucl Business Plc | Magnetic microbubbles, methods of preparing them and their uses |
-
2009
- 2009-11-12 ES ES09175794.8T patent/ES2600229T3/es active Active
- 2009-11-12 EP EP09175794.8A patent/EP2322142B1/de not_active Not-in-force
-
2010
- 2010-11-09 JP JP2012538311A patent/JP2013510817A/ja active Pending
- 2010-11-09 WO PCT/EP2010/067139 patent/WO2011058018A2/de active Application Filing
- 2010-11-09 US US13/509,353 patent/US20120283504A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008536837A (ja) * | 2005-04-12 | 2008-09-11 | マグフォース ナノテクノロジーズ アーゲー | ナノ粒子/活性成分結合体 |
WO2009070282A1 (en) * | 2007-11-26 | 2009-06-04 | Stc.Unm | Active nanoparticles and method of using |
Non-Patent Citations (1)
Title |
---|
JPN6014034837; 福森義宏 外1名: '"磁性細菌の生化学"' 日本生体磁気学会誌 Vol.14,No.1, 2001, P.64-65 * |
Also Published As
Publication number | Publication date |
---|---|
US20120283504A1 (en) | 2012-11-08 |
WO2011058018A3 (de) | 2011-11-24 |
WO2011058018A2 (de) | 2011-05-19 |
EP2322142B1 (de) | 2016-07-27 |
EP2322142A1 (de) | 2011-05-18 |
ES2600229T3 (es) | 2017-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5174654B2 (ja) | 官能基化された磁性ナノ粒子およびその使用法 | |
Akbarzadeh et al. | Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin | |
Nikiforov et al. | Biomedical applications of magnetic nanoparticles | |
Knežević et al. | Magnetic nanoarchitectures for cancer sensing, imaging and therapy | |
Häfeli | Magnetically modulated therapeutic systems | |
Nejati-Koshki et al. | Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer | |
Gambhir et al. | Multifunctional surface functionalized magnetic iron oxide nanoparticles for biomedical applications: A review | |
Arruebo et al. | Magnetic nanoparticles for drug delivery | |
Akbarzadeh et al. | RETRACTED ARTICLE: Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line | |
Qu et al. | Enhanced magnetic fluid hyperthermia by micellar magnetic nanoclusters composed of Mn x Zn1–x Fe2O4 nanoparticles for induced tumor cell apoptosis | |
Weissig et al. | Nanopharmaceuticals (part 2): products in the pipeline | |
Andreu et al. | Nano-objects for addressing the control of nanoparticle arrangement and performance in magnetic hyperthermia | |
Dobson | Magnetic nanoparticles for drug delivery | |
Hayashi et al. | High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect | |
Dai Tran et al. | Nanosized magnetofluorescent Fe3O4–curcumin conjugate for multimodal monitoring and drug targeting | |
Taylor et al. | Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imaging | |
Zoppellaro et al. | Theranostics of epitaxially condensed colloidal nanocrystal clusters, through a soft biomineralization route | |
Andrade et al. | Coating nanomagnetic particles for biomedical applications | |
Pantic | Magnetic nanoparticles in cancer diagnosis and treatment: novel approaches | |
Chen et al. | In vitro and in vivo CT imaging using bismuth sulfide modified with a highly biocompatible Pluronic F127 | |
JP2013510817A (ja) | 膠芽腫治療用生体適合性磁性ナノ粒子 | |
Thong et al. | Multifunctional nanocarriers of Fe3O4@ PLA-PEG/curcumin for MRI, magnetic hyperthermia and drug delivery | |
Rezk et al. | Thermo-responsive-polymeric-gates of poly (N-isopropylacrylamide)/N-(hydroxymethyl) acrylamide coated magnetic nanoparticles as a synergistic approach to cancer therapy: Drug release and kinetics models of chemothermal magnetic nanoparticles | |
Bayat et al. | Aptamer AS1411-functionalized gold nanoparticle-melittin complex for targeting MCF-7 breast cancer cell line | |
Ficai et al. | Advances in cancer treatment: role of nanoparticles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130809 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130809 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140819 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141031 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20141031 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20141031 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150331 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20151124 |